Standard
Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide. / Jeppesen, P.B.; Hartmann, Bolette; Thulesen, J.; Graff, J.; Lohmann, J.; Hansen, B.S.; Tofteng, F.; Poulsen, S.S.; Madsen, J.L.; Holst, J.J.; Mortensen, P.B.
I:
Today in Medicine. Gastroenterology, Nr. 120, 2001, s. 806-815.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Jeppesen, PB, Hartmann, B, Thulesen, J, Graff, J, Lohmann, J, Hansen, BS, Tofteng, F, Poulsen, SS, Madsen, JL, Holst, JJ & Mortensen, PB 2001, 'Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide', Today in Medicine. Gastroenterology, nr. 120, s. 806-815.
APA
Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, J. J., & Mortensen, P. B. (2001). Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide. Today in Medicine. Gastroenterology, (120), 806-815.
Vancouver
Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS o.a. Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide. Today in Medicine. Gastroenterology. 2001;(120):806-815.
Author
Jeppesen, P.B. ; Hartmann, Bolette ; Thulesen, J. ; Graff, J. ; Lohmann, J. ; Hansen, B.S. ; Tofteng, F. ; Poulsen, S.S. ; Madsen, J.L. ; Holst, J.J. ; Mortensen, P.B. / Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide. I: Today in Medicine. Gastroenterology. 2001 ; Nr. 120. s. 806-815.
Bibtex
@article{d5d1c51074c711dbbee902004c4f4f50,
title = "Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide",
author = "P.B. Jeppesen and Bolette Hartmann and J. Thulesen and J. Graff and J. Lohmann and B.S. Hansen and F. Tofteng and S.S. Poulsen and J.L. Madsen and J.J. Holst and P.B. Mortensen",
year = "2001",
language = "English",
pages = "806--815",
journal = "Today in Medicine. Gastroenterology",
issn = "1048-6771",
publisher = "Data Centrum Communications, Inc",
number = "120",
}
RIS
TY - JOUR
T1 - Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide
AU - Jeppesen, P.B.
AU - Hartmann, Bolette
AU - Thulesen, J.
AU - Graff, J.
AU - Lohmann, J.
AU - Hansen, B.S.
AU - Tofteng, F.
AU - Poulsen, S.S.
AU - Madsen, J.L.
AU - Holst, J.J.
AU - Mortensen, P.B.
PY - 2001
Y1 - 2001
M3 - Journal article
SP - 806
EP - 815
JO - Today in Medicine. Gastroenterology
JF - Today in Medicine. Gastroenterology
SN - 1048-6771
IS - 120
ER -
